BlackRock Fund Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $239M | Buy |
2,815,523
+119,024
| +4% | +$10.1M | 0.04% | 509 |
|
|
2016
Q3 | $201M | Buy |
2,696,499
+106,257
| +4% | +$7.92M | 0.04% | 537 |
|
|
2016
Q2 | $197M | Sell |
2,590,242
-960,353
| -27% | -$72.9M | 0.04% | 508 |
|
|
2016
Q1 | $246M | Sell |
3,550,595
-61,788
| -2% | -$4.28M | 0.06% | 383 |
|
|
2015
Q4 | $218M | Buy |
3,612,383
+144,062
| +4% | +$8.68M | 0.05% | 439 |
|
|
2015
Q3 | $188M | Sell |
3,468,321
-771,702
| -18% | -$41.8M | 0.05% | 471 |
|
|
2015
Q2 | $246M | Buy |
4,240,023
+7,967
| +0.2% | +$463K | 0.06% | 376 |
|
|
2015
Q1 | $255M | Buy |
4,232,056
+247,009
| +6% | +$14.9M | 0.06% | 361 |
|
|
2014
Q4 | $212M | Buy |
3,985,047
+365,910
| +10% | +$19.5M | 0.05% | 418 |
|
|
2014
Q3 | $162M | Sell |
3,619,137
-47,762
| -1% | -$2.14M | 0.05% | 499 |
|
|
2014
Q2 | $155M | Sell |
3,666,899
-233,265
| -6% | -$9.84M | 0.04% | 555 |
|
|
2014
Q1 | $172M | Buy |
3,900,164
+67,439
| +2% | +$2.97M | 0.05% | 455 |
|
|
2013
Q4 | $188M | Buy |
3,832,725
+73,202
| +2% | +$3.59M | 0.06% | 399 |
|
|
2013
Q3 | $155M | Buy |
3,759,523
+420,467
| +13% | +$17.3M | 0.05% | 446 |
|
|
2013
Q2 | $117M | Buy |
+3,339,056
| New | +$117M | 0.04% | 548 |
|